|
⚲
|
| Keyboard |
| Abeliovich Asa
✚
|
|
|---|---|
| CIK # | 0001778476 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001778476] | |
| 4 | [0001778476] | |
| SC 13G | [0001778476] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Abeliovich ASA | Prevail Therapeutics Inc | [2020-02-13] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Prevail Therapeutics Inc | |
| Abeliovich Asa |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 250,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Common Stock
|
2021-01-22 | Tender | 2,385,756 | ||
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 178,681 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 1,329,219 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2020-12-30 | Option exercise | 5,256 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2020-12-30 | Option exercise | 120,537 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Common Stock
|
2020-12-30 | Tax withheld | 89,037 | $23.02 | 2,049,632 |
|
Prevail Therapeutics Inc PRVL
Common Stock
|
2020-12-30 | Option exercise | 120,537 | $10.26 | 1,236,710 |
|
Prevail Therapeutics Inc PRVL
Common Stock
|
2020-12-30 | Option exercise | 5,256 | $0.18 | 946 |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2020-02-19 | Grant | 250,000 | $0.00 |